Clinical Risk Assessment and Comparison of Bias between Laboratory
Methods for Estimation of HbA1c for Glycated Hemoglobin in
Hyperglycemic Patients

Sukhes      Mukherjee; Prasant      Yadav; Suman   Kumar   Ray; Ashish   A.   Jadhav; Santosh   L.   Wakode

doi:10.2174/0115733998257140231011102518

Abstract

Introduction: Hemoglobin A1c (HbA1c), also known as glycated hemoglobin, is a blood test used to evaluate and track a patient's blood sugar levels over the previous 2-3 months. We have compared the analytical performance of the D10 hemoglobin (HPLC) testing system to that of the immunoturbidimetric technique, which is a light-scattering immunoassay.

Objectives: To assess the clinical risk assessment between two methods (Compare the two Immunoturbidometric methods (AU680) vs. HPLC method (D10)) in hyperglycemic patients and assess the acceptability of the respective methods in the Clinical biochemistry laboratory.

Methods: The charge of the globins in Hb was used as the basis for the HPLC method used to measure HbA1c. HPLC detects and quantifies even the tiniest Hb fractions and the full spectrum of Hb variants. HbA1c was measured using the immunoturbidimetric (AU 680 Beckmann coulter analyzer) and high-performance liquid chromatography (HPLC) techniques. Experiments also made use of immunoturbidimetric techniques (using an AU 680 Beckmann coulter analyzer equipment).

Results: There is no statistically significant difference in HbA1c readings between male and female patients, as measured by either the Immunoturbidimetric or HPLC techniques.

Conclusion: The immunoturbidimetric and high-performance liquid chromatography techniques for estimating HbA1c yielded identical results. From the results of this study, we may deduce that both techniques are valid for estimating HbA1c. As a result, it may be suggested that both approaches can be used to estimate HbA1c in diabetic individuals.

Keywords: HbA1c, risk assessment, immunoturbidimetric method, HPLC methods, quality control, glycated hemoglobin.

[1]
Kazmi NH, Gillani S, Afzal S, Hussain S. Correlation between glycated hemoglobin levels and random blood glucose. J Ayub Med Coll Abbottabad  2013; 25(1-2): 86-8.
 [PMID:  25098063]

[2]
English E, Milosevich E, John WG. In vitro determination of hemoglobin A1c for diabetes diagnosis and management: technology update. Pathol Lab Med Int  2014; 6: 21-31.

[3]
Bookchin RM, Gallop PM. Structure of hemoglobin AIc: Nature of the N-terminal β chain blocking group. Biochem Biophys Res Commun  1968; 32(1): 86-93.
 [http://dx.doi.org/10.1016/0006-291X(68)90430-0] [PMID:  4874776]

[4]
Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun  1969; 36(5): 838-43.
 [http://dx.doi.org/10.1016/0006-291X(69)90685-8] [PMID:  5808299]

[5]
Bunn HF, Haney DN, Gabbay KH, Gallop PM. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun  1975; 67(1): 103-9.
 [http://dx.doi.org/10.1016/0006-291X(75)90289-2] [PMID:  1201013]

[6]
Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med  1976; 295(8): 417-20.
 [http://dx.doi.org/10.1056/NEJM197608192950804] [PMID:  934240]

[7]
Sacks DB. Hemoglobin variants and hemoglobin A1c analysis: problem solved? Clin Chem  2003; 49(8): 1245-7.
 [http://dx.doi.org/10.1373/49.8.1245] [PMID:  12881436]

[8]
Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol  2009; 3(3): 446-51.
 [http://dx.doi.org/10.1177/193229680900300307] [PMID:  20144281]

[9]
Lin H, Yi J. Current status of HbA1c biosensors. Sensors (Basel)  2017; 17(8): 1798.
 [http://dx.doi.org/10.3390/s17081798] [PMID:  28777351]

[10]
Hawkins RC. Comparison of four point-of-care HbA1c analytical systems against central laboratory analysis. Singapore Med J  2003; 44(1): 8-11.
 [PMID:  12762557]

[11]
Moridani MY, Verjee Z, Allen LC. Analytical evaluation of hemoglobin A1c dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients. Clin Biochem  2003; 36(4): 317-20.
 [http://dx.doi.org/10.1016/S0009-9120(03)00013-4] [PMID:  12810162]

[12]
Khan MI, Weinstock RS.  Chapter 16: Carbohydrates.In: McPherson RA, Pincus MR, Eds Henry’s Clinical Diagnosis and Management by Laboratory Methods.  (22nd ed.). Philadelphia, PA: Saunders Elsevier 2011; pp. 210-25.
 [http://dx.doi.org/10.1016/B978-1-4377-0974-2.00016-6]

[13]
Nuttall FQ. Comparison of percent total GHb with percent HbA1c in people with and without known diabetes. Diabetes Care  1998; 21(9): 1475-80.
 [http://dx.doi.org/10.2337/diacare.21.9.1475] [PMID:  9727894]

[14]
Carbohydrates SD. Teitz textbook of Clinical Chemistry and Molecular Diagnostics.  (4th ed.).  2003; pp. 837-901.

[15]
Halwachs-Baumann G, Katzensteiner S, Schnedl W, Pürstner P, Pieber T, Wilders-Truschnig M. Comparative evaluation of three assay systems for automated determination of hemoglobin A1c. Clin Chem  1997; 43(3): 511-7.
 [http://dx.doi.org/10.1093/clinchem/43.3.511] [PMID:  9068596]

[16]
John WG, Mosca A, Weykamp C, Goodall I. HbA1c standardisation: history, science and politics. Clin Biochem Rev  2007; 28(4): 163-8.
 [PMID:  18392123]

[17]
Shiba T, Yano M, Maehata E, et al. Standardization of HbA1c value and its comparison to immunoassay — two years of experience. Diabetes Res Clin Pract  1996; 32(3): 175-82.
 [http://dx.doi.org/10.1016/0168-8227(96)01259-4] [PMID:  8858206]

[18]
Miedema K. Towards worldwide standardisation of HbA1c determination. Diabetologia  2004; 47(7): 1143-8.
 [http://dx.doi.org/10.1007/s00125-004-1453-0] [PMID:  15249996]

[19]
Kilpatrick ES. Hemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol  2008; 61(9): 977-82.
 [http://dx.doi.org/10.1136/jcp.2007.054304] [PMID:  18755721]

[20]
Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement. Diabetes Care  2007; 30(9): 2399-400.
 [http://dx.doi.org/10.2337/dc07-9925] [PMID:  17726190]

[21]
Baradaran A, Karami A. Comparative evaluation of three different methods for HbA1c measurement with High-performance liquid chromatography in diabetic patients. Adv Biomed Res  2014; 3(1): 94.
 [http://dx.doi.org/10.4103/2277-9175.129364] [PMID:  24800183]

[22]
Park MS, Lee K, Lee K, Song J, Park HD. Accurate and rapid measurement of glycated hemoglobin using HLC-723 G11 variant mode. Ann Lab Med  2019; 39(3): 237-44.
 [http://dx.doi.org/10.3343/alm.2019.39.3.237] [PMID:  30623615]

[23]
Thevarajah M, Yean CY, Nasir NM. Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements. Int J Diabetes Dev Ctries  2010; 30(2): 86-90.
 [http://dx.doi.org/10.4103/0973-3930.62598] [PMID:  20535312]

[24]
Rhea JM, Molinaro R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol  2014; 141(1): 5-16.
 [http://dx.doi.org/10.1309/AJCPQ23GTTMLAEVL] [PMID:  24343732]

[25]
Pohanka M. Glycated hemoglobin and methods for its point of care testing. Biosensors (Basel)  2021; 11(3): 70.
 [http://dx.doi.org/10.3390/bios11030070] [PMID:  33806493]

[26]
Kuchay MS, Yedla N, Mithal A. Hemoglobin E disease and glycosylated hemoglobin. Indian J Endocrinol Metab  2015; 19(5): 683-5.
 [http://dx.doi.org/10.4103/2230-8210.163211] [PMID:  26425484]

[27]
Hinzmann R, Schlaeger C, Tran CT. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci  2012; 9(8): 665-81.
 [http://dx.doi.org/10.7150/ijms.4520] [PMID:  23055818]

[28]
Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A view beyond HbA1c: Role of continuous glucose monitoring. Diabetes Ther  2019; 10(3): 853-63.
 [http://dx.doi.org/10.1007/s13300-019-0619-1] [PMID:  31037553]

[29]
Qaseem A, Wilt TJ, Kansagara D, et al. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American college of physicians. Ann Intern Med  2018; 168(8): 569-76.
 [http://dx.doi.org/10.7326/M17-0939] [PMID:  29507945]

[30]
Kaiafa G, Veneti S, Polychronopoulos G, et al. Is HbA1c an ideal biomarker of well-controlled diabetes? Postgrad Med J  2020; 10.
 [http://dx.doi.org/10.1136/postgradmedj-2020-138756] [PMID:  32913038]

[31]
Weykamp C. HbA1c: A review of analytical and clinical aspects. Ann Lab Med  2013; 33(6): 393-400.
 [http://dx.doi.org/10.3343/alm.2013.33.6.393] [PMID:  24205486]

[32]
Liu L, Hood S, Wang Y, et al. Direct enzymatic assay for %HbA1c in human whole blood samples. Clin Biochem  2008; 41(7-8): 576-83.
 [http://dx.doi.org/10.1016/j.clinbiochem.2008.01.013] [PMID:  18261468]

[33]
Speeckaert M, Van Biesen W, Delanghe J, et al. Are there better alternatives than hemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant  2014; 29(12): 2167-77.
 [http://dx.doi.org/10.1093/ndt/gfu006] [PMID:  24470517]

[34]
Freitas PAC, Ehlert LR, Camargo JL. Glycated albumin: a potential biomarker in diabetes. Arch Endocrinol Metab  2017; 61(3): 296-304.
 [http://dx.doi.org/10.1590/2359-3997000000272] [PMID:  28699985]

[35]
Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol  2007; 18(3): 896-903.
 [http://dx.doi.org/10.1681/ASN.2006070772] [PMID:  17267743]

[36]
Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA  2006; 295(14): 1688-97.
 [http://dx.doi.org/10.1001/jama.295.14.1688] [PMID:  16609091]

[37]
Wright LAC, Hirsch IB. Metrics beyond hemoglobin A1C in diabetes management: Time in range, hypoglycemia, and other parameters. Diabetes Technol Ther  2017; 19(S2): S-16-26.
 [http://dx.doi.org/10.1089/dia.2017.0029] [PMID:  28541136]

[38]
Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World J Diabetes  2019; 10(1): 1-15.
 [http://dx.doi.org/10.4239/wjd.v10.i1.1] [PMID:  30697366]

[39]
Little RR. Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med  2003; 41(9): 1191-8.
 [http://dx.doi.org/10.1515/CCLM.2003.183] [PMID:  14598869]

[40]
Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol  2011; 5(6): 1572-83.
 [http://dx.doi.org/10.1177/193229681100500634] [PMID:  22226280]

[41]
Beltran del Rio M, Tiwari M, Amodu LI, Cagliani J, Rodriguez Rilo HL. Glycated hemoglobin, plasma glucose, and erythrocyte aging. J Diabetes Sci Technol  2016; 10(6): 1303-7.
 [http://dx.doi.org/10.1177/1932296816659885] [PMID:  27422013]

[42]
Xu Y, Bergenstal RM, Dunn TC, Ajjan RA. Addressing shortfalls of laboratory HbA1c using a model that incorporates red cell lifespan. eLife  2021; 10e69456.
 [http://dx.doi.org/10.7554/eLife.69456] [PMID:  34515636]

[43]
Masuch A, Friedrich N, Roth J, Nauck M, Müller UA, Petersmann A. Preventing misdiagnosis of diabetes in the elderly: Age-dependent HbA1c reference intervals derived from two population-based study cohorts. BMC Endocr Disord  2019; 19(1): 20.
 [http://dx.doi.org/10.1186/s12902-019-0338-7] [PMID:  30755204]

[44]
Gordon DK, Hussain M, Kumar P, Khan S, Khan S. The sickle effect: The silent titan affecting glycated hemoglobin reliability. Cureus  2020; 12(8): e9685.
 [http://dx.doi.org/10.7759/cureus.9685] [PMID:  32923278]

[45]
Niwaha AJ, Rodgers LR, Greiner R, et al. HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: The OPTIMAL observational multicenter study. BMJ Open Diabetes Res Care  2021; 9(1): e002350.
 [http://dx.doi.org/10.1136/bmjdrc-2021-002350] [PMID:  34535465]

[46]
Lorenzo-Medina M, De-La-Iglesia S, Ropero P, Nogueira-Salgueiro P, Santana-Benitez J. Effects of hemoglobin variants on hemoglobin A1c values measured using a high-performance liquid chromatography method. J Diabetes Sci Technol  2014; 8(6): 1168-76.
 [http://dx.doi.org/10.1177/1932296814538774] [PMID:  25355712]

[47]
Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem  2002; 48(3): 436-72.
 [PMID:  11861436]

[48]
Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care  2011; 34(6): e61-99.
 [http://dx.doi.org/10.2337/dc11-9998] [PMID:  21617108]

[49]
Leow M. Glycated Hemoglobin (HbA1c): Clinical applications of a mathematical concept. Acta Inform Med  2016; 24(4): 233-8.
 [http://dx.doi.org/10.5455/aim.2016.24.233-238] [PMID:  27708483]

[50]
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights  2016; 11BMI: S38440.
 [http://dx.doi.org/10.4137/BMI.S38440] [PMID:  27398023]

[51]
Clark SL, Santin AE, Bryant PA, Holman R, Rodnick KJ. The initial noncovalent binding of glucose to human hemoglobin in nonenzymatic glycation. Glycobiology  2013; 23(11): 1250-9.
 [http://dx.doi.org/10.1093/glycob/cwt061] [PMID:  23926230]

[52]
Cabrales P, Salazar Vázquez MA, Salazar Vázquez B, Rodríguez-Morán M, Intaglietta M, Guerrero-Romeros F. Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients. Vasc Health Risk Manag  2008; 4(4): 917-22.
 [http://dx.doi.org/10.2147/VHRM.S3077] [PMID:  19066010]

[53]
Arkew M, Yemane T, Mengistu Y, Gemechu K, Tesfaye G. Hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia: A comparative cross-sectional study. PLoS One  2021; 16(6): e0253286.
 [http://dx.doi.org/10.1371/journal.pone.0253286] [PMID:  34125859]

[54]
Li Q, Yang LZ. Hemoglobin A1c level higher than 9.05% causes a significant impairment of erythrocyte deformability in diabetes mellitus. Acta Endocrinol  2018; 14(1): 66-75.
 [http://dx.doi.org/10.4183/aeb.2018.66] [PMID:  31149238]

[55]
Nayak AU, Singh BM, Dunmore SJ. Potential clinical error arising from use of hba1c in diabetes: Effects of the glycation gap. Endocr Rev  2019; 40(4): 988-99.
 [http://dx.doi.org/10.1210/er.2018-00284] [PMID:  31074800]

Rights & Permissions Print Cite

Article Metrics

10

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0115733998257140231011102518	Print ISSN 1573-3998
Publisher Name Bentham Science Publisher	Online ISSN 1875-6417

Current Diabetes Reviews

Clinical Risk Assessment and Comparison of Bias between Laboratory Methods for Estimation of HbA1c for Glycated Hemoglobin in Hyperglycemic Patients

Abstract

Related Journals

Related Books